Drug intelligence / Profile preview

Armonia

Development stage
Unknown
Lead developer
Regenyal Laboratories
Administration
Injectable, Intravaginal
01

Overview

Armonia is an injectable, multifractional intercalated cross-linked hyaluronic acid (MIC-HA) specifically designed for the treatment of Genitourinary Syndrome of Menopause (GSM) and vaginal atrophy. Developed by the Italian company Regenyal, it utilizes a proprietary cross-linking process to create a biopolymer that integrates into the vaginal extracellular matrix. Armonia functions by restoring tissue hydration through its high water-binding capacity and reinforcing the structural integrity of the vaginal wall. Beyond its physical properties as a filler, it also bio-stimulates the tissue by interacting with the CD44 receptor, which triggers a regenerative response characterized by increased collagen production, improved vascularization (angiogenesis), and enhanced cellular migration. This combined physical and biological action aims to alleviate symptoms such as vaginal dryness, itching, and dyspareunia, thereby improving sexual function and overall quality of life in postmenopausal women.

Brand names
Armonia
Other names
multifractional intercalated cross-linked hyaluronic acid
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on Armonia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Armonia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call